Drag a card by its title · ⚙ to size, swap or remove

The company

Q32 Bio Inc.

QTTB · Nasdaq

Health CareBiotechnologyNot moving yet

QTTB stood above a rising 150-day average in 46 of the last 52 weekly readings, and has been out of that trend for the last 5 weeks. It is 17.0% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 5
Industry in uptrend: 18% -9 in 4 wk
Insider buys, 12 months: $60.0M
Insider sales, 12 months: $856K
Officials’ trades on record: 0
Institutions holding: 68 (+17)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 46 of 52 weeks.

23 Apr – 22 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3

Sale orders, 12 months11

Buyers · sellers3 · 3

Who	Did	Shares	Traded
Lee KalowskiCFO and President	sold	1,301at $8.32	6 Oct 2026filed 14 Oct 2026
Shelia M. VioletteChief Scientific Officer	sold	917at $8.32	6 Oct 2026filed 14 Oct 2026
Jodie Pope MorrisonCEO	sold	3,221at $8.32	6 Oct 2026filed 14 Oct 2026
Shelia M. VioletteChief Scientific Officer	sold	2,798at $16.56	25 Aug 2026filed 27 Aug 2026
Jodie Pope MorrisonCEO	sold	9,845at $16.56	25 Aug 2026filed 27 Aug 2026
Lee KalowskiCFO and President	sold	3,972at $16.56	25 Aug 2026filed 27 Aug 2026
Orbimed Advisors LlcDirector, 10% owner	bought	1,250,000at $8.00	28 May 2026filed 1 Jun 2026
Orbimed Advisors LlcDirector, 10% owner	bought	625,000at $8.00	28 May 2026filed 1 Jun 2026
Diyong XuDirector, 10% owner	bought	1,250,000at $8.00	28 May 2026filed 1 Jun 2026
Diyong XuDirector, 10% owner	bought	625,000at $8.00	28 May 2026filed 1 Jun 2026
Shelia M. VioletteChief Scientific Officer	sold	2,815at $4.51	25 Feb 2026filed 27 Feb 2026
Jodie Pope MorrisonCEO	sold	9,896at $4.51	25 Feb 2026filed 27 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders68+17 on the quarter

New · exited27 · 9

Reported value$279.3M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
ORBIMED ADVISORS LLCadded · filed 14 Aug 2026	4,127,987$52.6M	+1,875,000+83.2%
Boxer Capital Management, LLCnew · filed 14 Aug 2026	3,149,310$40.1M	+3,149,310
Atlas Venture Life Science Advisors, LLCadded · filed 13 Aug 2026	2,717,106$34.6M	+625,000+29.9%
BVF INCnew · filed 14 Aug 2026	2,350,000$29.9M	+2,350,000
RA CAPITAL MANAGEMENT, L.P.new · filed 14 Aug 2026	2,332,457$29.7M	+2,332,457
Point72 Asset Management, L.P.new · filed 14 Aug 2026	1,173,396$14.9M	+1,173,396
Opaleye Management Inc.reduced · filed 14 Aug 2026	931,000$11.9M	-325,228−25.9%
Logos Global Management LPnew · filed 14 Aug 2026	800,000$10.2M	+800,000
SummitTX Capital, L.P.new · filed 14 Aug 2026	733,774$9.3M	+733,774
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	518,803$6.6M	+212,402+69.3%